Inhibition of JNK and ERK pathways by SP600125-and U0126-enhanced osteogenic differentiation of bone marrow stromal cells

Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 6, 2012, Pages 283-294

  Doan, Thi Kim Phuong ^a   Park, Kyung Soon ^a   Kim, Hyung Keun ^a,b   Park, Dae Sung ^a   Kim, Ji Hyun ^a   Yoon, Taek Rim ^a,b  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Inhibitors; Mitogen activated protein kinase; Osteogenic differentiation; SP600125; U0126

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BONE MARROW STROMAL CELLS; BONE MARROW STROMAL CELLS (BMSCS); BONE TISSUE ENGINEERING; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOGENIC DIFFERENTIATION; SP600125; U0126;

BONE; CALCIUM; CELL PROLIFERATION; CELLS; CORROSION INHIBITORS; ENZYME ACTIVITY; PHOSPHATASES; SIGNALING; TISSUE ENGINEERING;

CYTOLOGY;

EID: 84881465095     PISSN: 17382696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13770-012-0352-6     Document Type: Article

References (43)

1. RPM Bianco, S Gronthos, PG Robey, Bone marrow stromal stem cells: nature, biology, and potential applications, Stem Cells, 19, 180, (2001).
2. YTG Gafni, M Liebergal, G Pelled, et al., Stem cells as vehicles for orthopedic gene therapy, Gene Ther, 11, 417, (2004).
3. JB Lian, GS Stein, Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation, Critical Reviews In Oral Biol Med, 3, 269, (1992).
4. A Kapanen, Biocompatibility of orthopaedic implants on bone forming cells, Oulu Univ. (2002)
5. EML Cano, Parallel signal processing among mammalian MAPKs, Trends Biochem Sci, 20, 117, (1995).
6. C Marshall, Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation, Cell, 80, 179, (1995).
7. ZG Xia, M Dikens, J Raingesud, et al., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis, Science, 270, 1336, (1995).
8. M Haneda, T Sugimoto, R Kikkawa, Mitogenactivatedproteinkinase phosphatase: anegativeregulator of the mitogen-activatedproteinkinasecascade, Eur J Pharm, 365, 1, (1999).
9. J Raingeaud, S Gupta, JS Rogers, et al., Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine, J Biol Chem, 270, 7420, (1995).
10. JM Kyriakis, P Banerjee, E Nikolakaki, et al., The stressactivated protein kinase subfamily of c-Jun kinases, Nature, 369, 156, (1994).
11. KA Payne, LB Meszaros, JA Phillippi, et al., Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells, Tissue Eng Part A, 16, 3647, (2010).
12. S Iwasaki, M Iguchi, K Watanabe, et al., Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2, J Biol Chem, 274, 26503, (1999).
13. JA Engelman, MP Lisanti, PE Scherer, Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis, J Biol Chem, 273, 32111, (1998).
14. G Yoshimichi, T Nakanishi, T Nishida, et al., CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogenactivated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular- signal regulated kinase (ERK), Eur J Biochem, 268, 6058, (2001).
15. T Shimo, E Koyama, H Sugito, et al., Retinoid signaling regulates CTGF expression in hypertrophic chondrocytes with differential involvement of MAP kinases, J Bone Miner Res, 20, 867, (2005).
16. RK Jaiswal, N Jaiswal, SP Bruder, et al., Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase, J Biol Chem, 275, 9645, (2000).
17. LR Chaudhary, LV Avioli, Activation of c-Jun NH2-terminal kinases by interleukin-1β in normal human osteoblastic and rat UMR-106 cells, J Cell Biochem, 69, 87, (1998).
18. LR Chaudhary, LV Avioli, Activation of extracellular signalregulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells, Biochem Biophys Res Commun, 238, 134, (1997).
19. AK Kundu, CB Khatiwala, AJ Putnam, Extracellular matrix remodeling, integrin expression, and downstream signaling pathways influence the osteogenic differentiation of mesenchymal stem cells on poly(Lactide-Co-Glycolide) substrates, Tissue Eng Part , 15, 273, (2009).
20. Q Liu, L Cen, H Zhou, et al., The role of the extracellular signal-related kinase signaling pathway in osteogenic differentiation of human adipose-derived stem cells and in adipogenic transition initiated by dexamethasone, Tissue Eng Part A, 15, 3487, (2009).
21. S Peng, G Zhou, KDK Luk, et al., Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/ MAPK signaling pathway, Cell Physiol Biochem, 23, 165, (2009).
22. C Higuchi, A Myoui, N Hashimoto, et al., Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix, J Bone Miner Res, 17, 1785, (2002).
23. RA Jackson, A Kumarasuriyar, V Nurcombe, et al., Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells, J Cell Physiol, 209, 894, (2006).
24. P Collin, JR Nefussi, A Wetterwald, et al., Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture, Calcif Tissue Int, 50, 175, (1992).
25. FV Hartel, M Holl, M Arshad, et al., Transient hypoxia induces ERK-dependent anti-apoptotic cell survival in endothelial cells, Am J Physiol Cell Physiol, 298, 1501, (2010).
26. C Ambrosino, AR Nebreda, Cell cycle regulation by p38 MAP kinases, Biol Cell, 93, 47, (2001).
27. Z Wu, PJ Woodring, KS Bhakta, et al., p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps, Mol Cell Biol, 20, 3951, (2000).
28. RT Franceschi, The developmental control of osteoblastspecific gene expression: role of specific transcription factors and the extracellular matrix environment, Crit Rev Oral Biol Med, 10, 40, (1999).
29. F Gori, T Thomas, KC Hicok, et al., Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-1 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation, J Bone Miner Res, 14, 1522, (1999).
30. HC Anderson, JB Sipe, L Hessle, et al., Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice, Am J Pathol, 164, 841, (2004).
31. VI Sikavitsas, JS Temenoff, AG Mikos, Biomaterials and bone mechanotransduction, Biomaterials, 22, 2581, (2001).
32. Y Bai, K Matsuzaka, S Hashimoto, et al., Formation of bonelike tissue by dental follicle cells co-cultured with dental papilla cells, Cell Tissue Res, 342, 221, (2010).
33. C Desbois, DA Hogue, G Karsenty, The mouse osteocalcin Gene cluster contains three genes with two separate spatial and temporal patterns of expression, J Biol Chem, 269, 1183, (1994).
34. HH Luu, WX Song, X Luo, et al., Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells, J Orthop Res, 25, 665, (2007).
35. J Luo, MH Sun, Q Kang, et al., Gene therapy for bone regeneration, Curr Gene Ther, 5, 167, (2005).
36. H Cheng, W Jiang, FM Phillips, et al., Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs), J Bone Joint Surg Am, 85, 1544, (2003).
37. O Kozawa, D Hatakeyama, T Uematsu, Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts, J Cell Biochem, 84, 583, (2002).
38. AW Lund, JP Stegemann, GE Plopper, Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three dimensional, collagen I culture, Stem Cells Dev, 18, 331, (2008).
39. Y Hu, E Chan, SX Wang, et al., Activation of p38 mitogenactivated protein kinase is required for osteoblast differentiation, Endocrinology, 144, 2068, (2003).
40. J Guicheux, J Lemonnier, C Ghayor, et al., Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation, J Bone Miner Res, 18, 2060, (2003).
41. A Suzuki, J Guicheux, G Palmer, et al., Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation, Bone, 30, 91, (2002).
42. R Tuli, S Tuli, S Nandi, et al., Transforming growth factor-β- mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and wnt signaling cross-talk, J Biol Chem, 278, 41227, (2003).
43. U Noth, R Tuli, R Seghatoleslami, et al., Activation of p38 and smads mediates BMP-2 effects on human trabecular bonederived osteoblasts, Exp Cell Res, 291, 201, (2003).